A Prospective Multicenter Observational Real-world Study of Retained Products of Conception

Recruiting now

Conditions studied: Retained Products of Conception, RPOC

In brief

The purpose of this study is to explore the optimal treatment strategy for retained products of pregnancy. Compared with surgical treatment, prospectively observe whether drug-assisted expectant management until the right time for surgery reduce the occurrence of intrauterine adhesions, and thus protect fertility.

Key facts

Study ID

NCT07421895

Run by

The Third Xiangya Hospital of Central South University

People needed

600

Starts

2022-06-01

Expected to finish

2032-12-31

Last updated by the study team

2026-02-19

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

Where it is running

• The Third Xiangya Hospital of Central South University — Changsha, Hunan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.